You're not alone: Kelowna has a vibrant Crohn’s and colitis community, made up of people with inflammatory bowel disease, families, volunteers, and more. Throughout the year, we come together at meetings and events like the Gutsy Walk to share experiences, raise funds and heighten awareness.

There are an estimated 1,300 people with Crohn’s disease or ulcerative colitis in the Kelowna community. We understand the challenges you and your family may be facing – because we face them, too.


 
Rory Hornstein

Ask the Expert on Diet and Lifestyle in IBD!

Join us virtually on May 8 2024, at 8:00 pm ET to connect with Rory Hornstein, a Registered Dietitian who not only lives with inflammatory bowel disease but is also a caregiver to someone with ...

 • 
Virtual
 • 
Speaker giving a presentation

Fertility and Pregnancy in Crohn’s and Colitis

Fertility and Pregnancy in Crohn’s and ColitisDate: September 12, 2024Time: 7:00 - 8:30 p.m. ET Did you know that Crohn’s and colitis may impact the fertility of both men and women ...

 • 
ZOOM (Virtual)
 • 
Speaker giving a presentation

Ostomy Care in Crohn’s and Colitis

Ostomy Care in Crohn’s and ColitisDate: October 8, 2024Time: 7:00 - 8:30 p.m. ET Are you, or a loved one, getting ready to live with an ostomy? Have you ever wondered how to maintain a ...

 • 
ZOOM (Virtual)
 • 
Speaker giving a presentation

From Childhood to the Elderly: Navigating IBD Care

From Childhood to the Elderly: Navigating IBD CareDate: November 26, 2024Time: 7:00 - 8:30 p.m. ET Have you ever wondered how Crohn’s disease and ulcerative colitis impact different age ...

 • 
ZOOM (Virtual)
 • 
Speaker giving a presentation

Pain in Crohn's and Colitis

Pain in Crohn’s and Colitis Date: December 5, 2024 Time: 7:00 - 8:30 p.m. ET  Are you or a loved one struggling with pain when living with Crohn's disease or ulcerative colitis? Have ...

 • 
ZOOM (Virtuel)
 • 

Facebook

More on Facebook
 
Remember to bookmark this page.

News

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada

Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada

 8 9 10 11 12 13 14 15 16 17